Metraipolis › archive › dc_a46832e36d2e

Retromer-targeted therapy for neurodegenerative diseases — Europe PMC PMID:42723096

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42723096
DOI
10.1186/s13024-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-10-15T19:44:27.848Z
SHA-256 of the archived text
51a464f0e26d1e51aa24cd37c50bc118465b14a5676f8caa66c26972d8ae3f2f
Stable URL of this page
https://metraipolis.com/documento/dc_a46832e36d2e

How to cite

Retromer-targeted therapy for neurodegenerative diseases — Europe PMC PMID:42723096 — Europe PMC (en), https://europepmc.org/article/MED/42723096 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a46832e36d2e (Metraipolis archive dc_a46832e36d2e, sha256 51a464f0e26d1e51aa24cd37c50bc118465b14a5676f8caa66c26972d8ae3f2f)
BibTeX
@misc{dca46832e36d2e,
  title = {Retromer-targeted therapy for neurodegenerative diseases — Europe PMC PMID:42723096},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42723096},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a46832e36d2e; sha256 51a464f0e26d1e51aa24cd37c50bc118465b14a5676f8caa66c26972d8ae3f2f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42723096. Agents can read the archived copy with the MCP tool read_document.